Global Ship Lease Announces Annual Meeting of Shareholders
May 03, 2024 16:15 ET
|
Global Ship Lease Inc.
ATHENS, Greece, May 03, 2024 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE:GSL) (the “Company”) has scheduled its Annual Meeting of Shareholders for June 17, 2024, at 10:00 a.m. Eastern Time...
Hudson Global to Report First Quarter 2024 Financial Results on May 10th
May 03, 2024 16:15 ET
|
Hudson Global, Inc.
OLD GREENWICH, Conn., May 03, 2024 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON), a leading global talent solutions company, will issue its first quarter financial results for the period...
Signing Day Sports Provides Announcement on Its Annual Report
May 03, 2024 16:15 ET
|
Signing Day Sports, Inc.
SCOTTSDALE, Ariz, May 03, 2024 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to...
The Chemours Company Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds The Chemours Company Shareholders of Deadline in Securities Fraud Class Action Lawsuit (CC)
May 03, 2024 16:15 ET
|
Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against...
Wolf Popper LLP Announces Investigation on Behalf of Vestis Corporation Investors
May 03, 2024 16:05 ET
|
Wolf Popper LLP
Wolf Popper LLP Announces Investigation on Behalf of
Vestis Corporation Investors
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
May 03, 2024 16:05 ET
|
Aileron Therapeutics, Inc.
AUSTIN, Texas, May 03, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:05 ET
|
Taysha Gene Therapies, Inc.
DALLAS, May 03, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the...
Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination
May 03, 2024 16:05 ET
|
Kernel Group Holdings, Inc
New York, May 03, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) (“KRNL” or the “Company”), a special purpose acquisition company, announced today that it has...
Taitron Announces Quarterly Cash Dividend
May 03, 2024 16:05 ET
|
Taitron Components Incorporated
LOS ANGELES, May 03, 2024 (GLOBE NEWSWIRE) -- Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of...
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
May 03, 2024 16:05 ET
|
electroCore, Inc.
ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1,...